"The Accumulus Connector is designed to make the regulatory network accessible directly from within the systems companies already use, streamlining the approval process."
"Getting a drug approved in multiple countries simultaneously requires filing the same information with dozens of different national regulatory authorities, each with their own systems, formats, and timelines."
"The platform enables what the industry calls 'reliance pathways', allowing regulators in one country to leverage the review work of a regulator in another."
Accumulus Technologies, a SaaS company from Accumulus Synergy, launched the Accumulus Connector to facilitate drug approvals across over 70 countries. The platform connects pharmaceutical and biotech companies to various national regulatory authorities, addressing the inefficiencies of manual reconciliation and submission duplication. By enabling simultaneous submissions and reliance pathways, the Connector aims to expedite the approval process, allowing therapies to reach patients more quickly. This innovation is crucial for companies navigating complex regulatory environments and seeking to optimize their submission timelines.
Read at TNW | Launch
Unable to calculate read time
Collection
[
|
...
]